A. Arzhankin vs A. Bellifemine — prediction

The core signal here is the rating gap: 1582 for Arzhankin against 1417 for Bellifemine, a substantial 165-point difference on the Elo scale that explains most of the model's 72% probability for the favorite. At this level, a gap of this size typically reflects a real difference in consistency and quality across matches, even without surface, serve, or return data to refine the picture further.

It's worth flagging that this Elo estimate comes from a soft Challenger/ITF market — thinner data, less scrutiny, and more noise than tour-level markets. The rating gap is real, but the confidence around it should be tempered accordingly.

Arzhankin's last 10 matches show a 6-4 record (LWWWWLWLLW), while Bellifemine sits at 4-6 (LLLLWWLWLW). Both are on a one-match win streak, so the current momentum snapshot is a coin flip, but the trailing 10-match window gives Arzhankin a mild edge — win totals that don't dramatically shift the read established by Elo but reinforce the favorite's slightly steadier recent output.

Neither player shows a quality win flagged in the data, so this form read is based purely on match outcomes, not on strength of opposition beaten.

Both players return from a one-day rest, so neither carries a freshness advantage on that front. Where it differs is recent workload: Arzhankin has played 2 matches in the last 14 days against Bellifemine's 1, a small additional physical load on the favorite heading into this match, though not enough on its own to offset the Elo and form gaps.

The odds of 1.22 imply an 82% win probability for Arzhankin, but the model's independent estimate is 72% — a 10-point gap that translates into a -12% expected value at this price. In plain terms: even though Arzhankin is the rightful favorite on rating and form, the market is pricing him more confidently than the data supports, making this a case where being the favorite does not equal being the value side.

This estimate comes from a soft ITF-level Elo model, not a fully calibrated factor system, so the edge should be treated as directional rather than proven. Bet sizing or interest here should reflect that this is closer to a fair-or-slightly-negative price than an exploitable mispricing.